Allergan Plc
NYSE:AGN (5/8/2020, 7:04:06 PM)
After market: 193.7 +0.68 (+0.35%)193.02
+0.03 (+0.02%)
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Allergan Plc
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK
DUBLIN L2 D17 E400
P: 862-261-7000
CEO: Brenton L. Saunders
AbbVie's (ABBV) wrinkle therapy Botox-led aesthetics franchise may benefit from the increasing demand for obesity drugs in the long-term. Find out the reasons.
Despite increasing competition, AbbVie reportedly expects Botox to maintain its leading market share position in the aesthetics market. Read more here.
BioMarin's shares surge 12% after activist investor Elliott Management takes $1 billion stake; potential takeover target for larger cap peer.
AbbVie (ABBV) Allergan Aesthetics reports positive Phase 3 results for its new wrinkle therapy, BoNT/E, for the treatment of glabellar lines between eyebrows. Read more here.
Get an extensive Obesity Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Here you can normally see the latest stock twits on AGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: